Exact Sciences Corp (NASDAQ: EXAS): Stock That Needs Special Handling
Currently, there are 185.08M common shares owned by the public and among those 182.38M shares have been available to trade. The company’s stock has a 5-day price change of 11.46% and -1.72% over the past three months. EXAS shares are trading -18.76% year to date (YTD), with the 12-month market performance down to -8.69% lower. […]
Exact Sciences Corp (EXAS): Not A Time To Panic Nor Freeze
Exact Sciences Corp (EXAS) concluded trading on Wednesday at a closing price of $50.73, with 7.09 million shares of worth about $359.49 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.89% during that period and on November 13, 2024 the price saw a […]
Analysts Update Their Price Forecasts For Exact Sciences Corp (EXAS)
Exact Sciences Corp (EXAS) concluded trading on Wednesday at a closing price of $54.72, with 16.74 million shares of worth about $915.84 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.00% during that period and on November 06, 2024 the price saw a […]
An Important Check-Up On Exact Sciences Corp. (NASDAQ: EXAS)
Exact Sciences Corp. (EXAS) concluded trading on Thursday at a closing price of $67.94, with 2.84 million shares of worth about $192.98 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.58% during that period and on September 26, 2024 the price saw a […]
Exact Sciences Corp. (NASDAQ: EXAS): Reassessing Prospects
Exact Sciences Corp. (EXAS) concluded trading on Thursady at a closing price of $59.49, with 4.62 million shares of worth about $274.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.33% during that period and on Thursady the price saw a loss of […]
Exact Sciences Corp. (NASDAQ: EXAS): Do Not Miss The Gain Train
JPMorgan Investment Management, I has recently announced that it has increased stake in Exact Sciences Corp. (NASDAQ:EXAS) by 24.60%. After grabbing 15.33 million shares, the institutional investor is now in possession of 3.03 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.48% having worth around $981.42 million. […]
